RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

Tissue penetration device

  • US 7,981,055 B2
  • Filed: 12/22/2005
  • Issued: 07/19/2011
  • Est. Priority Date: 06/12/2001
  • Status: Active Grant
  • ×

    Create Patent Alert


    *Certain alert events are not available for your current subscription level. Upgrade
  • Save